Medicine
Volume 36, Issue 6 , Pages 309-314 , June 2008

Pulmonary sarcoidosis

References 

  1. Wasfi Y, Newman LS. Sarcoidosis. In:  Mason RJ,  Broaddus VC,  Murray JF,  Nadel JA editor. Textbook of respiratory medicine. 4th edn. Philadelphia: Elsevier Saunders; 2005;
  2. American Thoracic Society , European Respiratory Society . World association of sarcoidosis and other granulomatous disorders. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736–755
  3. Martin WJ, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research. Summary of an NHLBI Working Group. Am J Respir Crit Care Med. 2004;170:567–571
  4. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Resp Crit Care Med. 2007;28:22–35
  5. Newman LS, Rose CS, Bresnitz EA, et al. A case-control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–1330
  6. Newman-Taylor A, Cullinan P. Sarcoidosis: in search of a cause. Am J Respir Crit Care Med. 2004;170:1268–1269
  7. Iannuzzi MC. Genetics of sarcoidosis. Semin Resp Crit Care Med. 2007;28:15–21
  8. Grunewald J, Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc. 2007;4:461–464
  9. Gibson GJ. Sarcoidosis: old and new treatments. (editorial) Thorax. 2001;56:336–339
  10. Paramothayan S, Lasserson T. Treatments for pulmonary sarcoidosis. Respir Med. 2008;102:1–9
  11. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society sarcoidosis study: effects of long-term corticosteroid therapy. Thorax. 1996;51:238–247
  12. Odlum CM, FitzGerald MX. Evidence that steroids alter the natural history of previously progressive pulmonary sarcoidosis. Sarcoidosis. 1986;3:40–46
  13. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174:795–802
  14. Arcasoy SM, Christie JD, Pochettino A, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest. 2001;120:873–880
  15. Shorr AF, Helman DL, Davies DB, Nathan SD. Sarcoidosis, race and short-term outcomes following lung transplantation. Chest. 2004;125:990–996

PII: S1357-3039(08)00098-4

doi: 10.1016/j.mpmed.2008.03.005

Medicine
Volume 36, Issue 6 , Pages 309-314 , June 2008

Article Tools

* Image Usage & Resolution